• Users Online: 2688
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 10  |  Issue : 3  |  Page : 190-195

Tumor markers in oral squamous cell carcinoma as an adjunct to diagnosis: An insight

Department of Oral Pathology, Microbiology and Forensic Odontology, Himachal Institute of Dental Sciences, Paonta, Sahib, Himachal Pradesh, India

Correspondence Address:
Dr Monika Negi
Department of Oral and Maxillofacial Pathology, Himachal Institute of Dental Sciences, Paonta Sahib, Himachal Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/IJDS.IJDS_53_18

Rights and Permissions

The topic of tumor markers is an immeasurable one, and there is an opulence of data collected till now. It has been deduced that tumor markers can suffice as an acceptable screening test for initiating definitive diagnostic procedures with a goal of making an “early diagnosis.” Through modern techniques of sensitive immunoassays such as radioimmunoassay and enzyme-linked immunosorbent assay, quantitative as well as qualitative evaluation of these markers is possible. Most tumor markers are substances produced by some types of nonneoplastic cells, although perhaps in much lower quantities than they are produced by tumor cells. The review article on tumor markers in oral squamous cell carcinoma (OSCC) as an adjunct to diagnosis is grounded totally on our analysis, consultation, experience, exploration, reviews, and original articles on the subject. Guidelines have been developed by various national skillful and international Oracle groups for the use of tumor markers for cancers, but none of these are currently formalized to maneuver in OSCC. It has been concluded that tumor markers cannot be maneuvered as fundamental modalities for the diagnosis of oral cancer. Tumor markers' main profitability in clinical medicine has been a laboratory test to support the diagnosis; further detailed studies are required to determine their practical usefulness in clinical workflow. It cannot be used as a sole diagnostic tool but can be used as an adjunct to routine histopathology using hematoxylin and eosin stain. Instead by combining various tumor markers, we can achieve a great specificity and sensitivity in the follow-up of one type of malignancy, for example, OSCC.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1444    
    Comments [Add]    
    Cited by others 2    

Recommend this journal